Table: begin end state 1 12 non-cytoplasmic 13 47 transmembrane 48 58 cytoplasmic 59 80 transmembrane 81 106 non-cytoplasmic 107 131 transmembrane 132 142 cytoplasmic 143 162 transmembrane 163 167 non-cytoplasmic 168 188 transmembrane 189 199 cytoplasmic 200 220 transmembrane 221 261 non-cytoplasmic 262 285 transmembrane 286 324 cytoplasmic 325 346 transmembrane 347 357 non-cytoplasmic 358 381 transmembrane 382 392 cytoplasmic 393 412 transmembrane 413 419 non-cytoplasmic 420 447 transmembrane 448 466 cytoplasmic 467 490 transmembrane 491 506 non-cytoplasmic
Input: >GFF369 MLELLQQGFGAVFSLNILLLMLGGVAVGIVFGAVPGLSATMAVALCLPLTFTMGPQAGLS LLVALFIGATSGGLISAILLKIPGTPSSIATVFDGGPLMEQGMGVKALGVGIVFSFLGTI FSIIALMFIAPQLAKVALSFGPHEYFAIAVFSLTLIATLSAGSMVKGLFAGTLGIAVSTV GIAPVEAVRRFTFGVSELNGGFSMLTVMIGMFAVAEVIKLAETGRHAVRNKAGSVSMKQI KGFGFSLKEFRQELPNATRSGLIGLAVGILPGIGAGTSNLLSYIVAKKRAKQPETYGKGN IGGVVASETANNAGIGGAMMPLMTLGIPGDTTTAILLGGFLIHGIQPGPLLFISQGPLVY TIFAALLVASVMMLFMEFYGLRLFIKLLDVPKHILLPIILVLCVVGAFGLSSRLFDVWSI LLFGVLGYGFVKAGMPVAPFIIGFILGPMAETNLRRGLMLSDGNFASFFTNPIAATFLGL ALAFVLWQLYSAMRPRSGVLGQALRT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server